An inhibitor of ROCK1 and ROCK2 and an active metabolite of HA-1077
Related Products
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Hydroxyfasudil

Item No. 40814

Technical Information
Formal Name
5-[(hexahydro-1H-1,4-diazepin-1-yl)sulfonyl]-1(2H)-isoquinolinone
CAS Number
105628-72-6
Molecular Formula
C14H17N3O3S
Formula Weight
Purity
≥98%
A solid
DMSO: Slightly soluble: 0.1-1 mg/ml
SMILES
O=C1NC=CC2=C(S(=O)(N3CCCNCC3)=O)C=CC=C21
InChi Code
InChI=1S/C14H17N3O3S/c18-14-12-3-1-4-13(11(12)5-7-16-14)21(19,20)17-9-2-6-15-8-10-17/h1,3-5,7,15H,2,6,8-10H2,(H,16,18)
InChi Key
ZAVGJDAFCZAWSZ-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    Hydroxyfasudil is an inhibitor of ROCK1 and ROCK2 (IC50s = 0.15 and 0.57 µM, respectively) and an active metabolite of the Rho-associated kinase (ROCK) inhibitor HA-1077 (fasudil; Item No. 10010559).1 In vivo, hydroxyfasudil (3 and 10 mg/kg) decreases blood viscosity and prevents cerebral vasospasm in a canine model of subarachnoid hemorrhage.2 Hydroxyfasudil also reverses hypertension-associated dysfunction of relaxation induced by nitric oxide in corpus cavernosum smooth muscle in spontaneously hypertensive rats.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Zaky, Y.A., Rashad, M.W., Zaater, M.A., et alDiscovery of dual rho-associated protein kinase 1 (ROCK1)/apoptosis signal-regulating kinase 1 (ASK1) inhibitors as a novel approach for non-alcoholic steatohepatitis (NASH) treatment. BMC Chem. 18(1), 2 (2024).

    2. Satoh, S., Takayasu, M., Kawasaki, K., et alAntivasospastic effects of hydroxyfasudil, a Rho-kinase inhibitor, after subarachnoid hemorrhage. J. Pharmacol. Sci. 118(1), 92-98 (2012).

    3. Saito, M., Ohmasa, F., Dimitriadis, F., et alHydroxyfasudil ameliorates penile dysfunction in the male spontaneously hypertensive rat. Pharmacol. Res. 66(4), 325-331 (2012).